Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Abstract Ionizable lipid nanoparticles (LNPs) are the most clinically advanced nano‐delivery system for therapeutic nucleic acids. The great effort put in the development of ionizable lipids with increased in vivo potency brought LNPs from the laboratory benches to the FDA approval of patisiran in 2...

Full description

Bibliographic Details
Main Authors: Michele Schlich, Roberto Palomba, Gabriella Costabile, Shoshy Mizrahy, Martina Pannuzzo, Dan Peer, Paolo Decuzzi
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Bioengineering & Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/btm2.10213
_version_ 1818453689076023296
author Michele Schlich
Roberto Palomba
Gabriella Costabile
Shoshy Mizrahy
Martina Pannuzzo
Dan Peer
Paolo Decuzzi
author_facet Michele Schlich
Roberto Palomba
Gabriella Costabile
Shoshy Mizrahy
Martina Pannuzzo
Dan Peer
Paolo Decuzzi
author_sort Michele Schlich
collection DOAJ
description Abstract Ionizable lipid nanoparticles (LNPs) are the most clinically advanced nano‐delivery system for therapeutic nucleic acids. The great effort put in the development of ionizable lipids with increased in vivo potency brought LNPs from the laboratory benches to the FDA approval of patisiran in 2018 and the ongoing clinical trials for mRNA‐based vaccines against SARS‐CoV‐2. Despite these success stories, several challenges remain in RNA delivery, including what is known as “endosomal escape.” Reaching the cytosol is mandatory for unleashing the therapeutic activity of RNA molecules, as their accumulation in other intracellular compartments would simply result in efficacy loss. In LNPs, the ability of ionizable lipids to form destabilizing non‐bilayer structures at acidic pH is recognized as the key for endosomal escape and RNA cytosolic delivery. This is motivating a surge in studies aiming at designing novel ionizable lipids with improved biodegradation and safety profiles. In this work, we describe the journey of RNA‐loaded LNPs across multiple intracellular barriers, from the extracellular space to the cytosol. In silico molecular dynamics modeling, in vitro high‐resolution microscopy analyses, and in vivo imaging data are systematically reviewed to distill out the regulating mechanisms underlying the endosomal escape of RNA. Finally, a comparison with strategies employed by enveloped viruses to deliver their genetic material into cells is also presented. The combination of a multidisciplinary analytical toolkit for endosomal escape quantification and a nature‐inspired design could foster the development of future LNPs with improved cytosolic delivery of nucleic acids.
first_indexed 2024-12-14T21:42:58Z
format Article
id doaj.art-59727285d9c041cfa4813bef3b0fc601
institution Directory Open Access Journal
issn 2380-6761
language English
last_indexed 2024-12-14T21:42:58Z
publishDate 2021-05-01
publisher Wiley
record_format Article
series Bioengineering & Translational Medicine
spelling doaj.art-59727285d9c041cfa4813bef3b0fc6012022-12-21T22:46:25ZengWileyBioengineering & Translational Medicine2380-67612021-05-0162n/an/a10.1002/btm2.10213Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticlesMichele Schlich0Roberto Palomba1Gabriella Costabile2Shoshy Mizrahy3Martina Pannuzzo4Dan Peer5Paolo Decuzzi6Fondazione Istituto Italiano di Tecnologia Laboratory of Nanotechnology for Precision Medicine Genoa ItalyFondazione Istituto Italiano di Tecnologia Laboratory of Nanotechnology for Precision Medicine Genoa ItalyFondazione Istituto Italiano di Tecnologia Laboratory of Nanotechnology for Precision Medicine Genoa ItalyFondazione Istituto Italiano di Tecnologia Laboratory of Nanotechnology for Precision Medicine Genoa ItalyFondazione Istituto Italiano di Tecnologia Laboratory of Nanotechnology for Precision Medicine Genoa ItalyLaboratory of Precision NanoMedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences Tel Aviv University Tel Aviv IsraelFondazione Istituto Italiano di Tecnologia Laboratory of Nanotechnology for Precision Medicine Genoa ItalyAbstract Ionizable lipid nanoparticles (LNPs) are the most clinically advanced nano‐delivery system for therapeutic nucleic acids. The great effort put in the development of ionizable lipids with increased in vivo potency brought LNPs from the laboratory benches to the FDA approval of patisiran in 2018 and the ongoing clinical trials for mRNA‐based vaccines against SARS‐CoV‐2. Despite these success stories, several challenges remain in RNA delivery, including what is known as “endosomal escape.” Reaching the cytosol is mandatory for unleashing the therapeutic activity of RNA molecules, as their accumulation in other intracellular compartments would simply result in efficacy loss. In LNPs, the ability of ionizable lipids to form destabilizing non‐bilayer structures at acidic pH is recognized as the key for endosomal escape and RNA cytosolic delivery. This is motivating a surge in studies aiming at designing novel ionizable lipids with improved biodegradation and safety profiles. In this work, we describe the journey of RNA‐loaded LNPs across multiple intracellular barriers, from the extracellular space to the cytosol. In silico molecular dynamics modeling, in vitro high‐resolution microscopy analyses, and in vivo imaging data are systematically reviewed to distill out the regulating mechanisms underlying the endosomal escape of RNA. Finally, a comparison with strategies employed by enveloped viruses to deliver their genetic material into cells is also presented. The combination of a multidisciplinary analytical toolkit for endosomal escape quantification and a nature‐inspired design could foster the development of future LNPs with improved cytosolic delivery of nucleic acids.https://doi.org/10.1002/btm2.10213endosomal escapeintracellular deliveryionizable lipidsLNPsmRNARNA delivery
spellingShingle Michele Schlich
Roberto Palomba
Gabriella Costabile
Shoshy Mizrahy
Martina Pannuzzo
Dan Peer
Paolo Decuzzi
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
Bioengineering & Translational Medicine
endosomal escape
intracellular delivery
ionizable lipids
LNPs
mRNA
RNA delivery
title Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
title_full Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
title_fullStr Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
title_full_unstemmed Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
title_short Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
title_sort cytosolic delivery of nucleic acids the case of ionizable lipid nanoparticles
topic endosomal escape
intracellular delivery
ionizable lipids
LNPs
mRNA
RNA delivery
url https://doi.org/10.1002/btm2.10213
work_keys_str_mv AT micheleschlich cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles
AT robertopalomba cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles
AT gabriellacostabile cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles
AT shoshymizrahy cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles
AT martinapannuzzo cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles
AT danpeer cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles
AT paolodecuzzi cytosolicdeliveryofnucleicacidsthecaseofionizablelipidnanoparticles